Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Women-focused investment strategies are designed to meet your unique financial goals. Tailor your investment approach for success.
22,324 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
FUTY has delivered 64% returns over five years while charging just 0.084% in fees, as the utility sector blends stead...
The market has sprinted higher, and valuations feel stretched. History, however, shows that corrections are a normal ...
In May, a calmer approach can shine. This article highlights two dividend stocks that are no-brainer buys for conserv...
Solana surged 13% last week, its strongest performance of 2026, driven by ETF demand and higher futures activity. Tra...
Trump-backed candidates swept a Louisiana GOP primary, underscoring ongoing party loyalty. Markets watched political ...
Super Micro Computer led AI infra shares higher today as demand for AI servers strengthens. The move contrasts with m...
A synthetic covered‑call ETF on MicroStrategy stock continues to pay outs through monthly distributions, yet the stra...
JPMorgan's JEPI ETF offers a compelling income stream through covered calls on a diversified 110-name portfolio. This...
Zcash (ZEC) shows a renewed bullish setup as a 12-hour TD Sequential buy signal appears, with traders eyeing a potent...
A famous three word reply from a royal moment inspired a practical approach to personal finance. Learn how concise me...
Bitcoin briefly dipped below $60,000 on Friday, sparking questions about XRP’s fate. While XRP moved in tandem, signs...